A comprehensive treatment system for tumor classification in the guidelines for the research of new

It is a systematic process, which requires effective multidisciplinary collaboration such as minimally invasive intervention, high-intensity focused ultrasound, DC-CIK biological immunity, surgery, radiotherapy and chemotherapy to be successfully completed. Although the comprehensive plan is not a mechanical and immutable fixed model after the formulation, it may be appropriately adjusted with the gradual improvement of diagnosis and the difference in efficacy in the specific diagnosis and treatment process, such as the comprehensive plan formulated before surgery may be appropriately adjusted according to the surgical situation and postoperative pathological examination results, but the adjustment of each program should have a scientific basis.

Because the biological immunity technology uses the body's own immune cells, rather than traditional chemicals to kill tumor cells, the technology is safe and non-toxic, suitable for all stages of cancer, and has been carried out for countless cancer patients to relieve the pain of the disease, bringing health gospel!

Tumor biology is the latest tumor technology superior to surgery, radiotherapy and chemotherapy, and it is a method of cultivating autologous immune cells that can kill tumors in a high-standard laboratory through biotechnology, and then infusing them back into the body to directly kill cancer cells. Different from the traditional method, tumor biology directly identifies and destroys cancer cells existing in the blood and lymph of the human body without damaging the body's immune system and function, and restores and enhances the body's natural anti-cancer immune system and function. Tumor biology has the advantages of no harm to the body, no need for hospitalization, etc., can improve the patient's own immunity and quality of life, and is suitable for all tumor diseases, and the biological technology has been officially applied to clinical practice.

The book "Guidelines for the Research of New Anti-Cancer Drugs" edited by Chen Qingqi introduces you to the new small molecule anti-cancer drugs currently in clinical research around the world, some of which will gradually become new human beings to defeat cancer in the next 20 years. This book reflects the overall level and current situation of the research and development of new anti-cancer drugs in human beings from one side. The book "Guidelines for the Research of New Anti-cancer Drugs" was edited by Chen Qingqi and published by Science Press in March 2009.

ISBN 9787030234407, 16 pages.

The comprehensive tumor classification introduced in Chemotherapy and Targeted Lung Cancer is based on the patient's physical condition, the pathological type of the tumor, the scope of invasion and the development trend, and the planned and reasonable application of existing methods to maximize the rate and improve the quality of life. It is the best plan for tumors at this stage, and it is the basic principle of most tumors at present.

The comprehensive tumor is not a simple combination of minimally invasive intervention, high-intensity focused ultrasound, DC-CIK biological immunity, surgery, radiotherapy and chemoradiotherapy, but a planned, step-by-step, and sequential individualized collection, which is a systematic process, which requires effective multidisciplinary collaboration such as minimally invasive intervention, high-intensity focused ultrasound, DC-CIK biological immunity, surgery, radiotherapy and chemotherapy to be successfully completed. Although the comprehensive plan is not a mechanical and immutable fixed model after the formulation, it may be appropriately adjusted with the gradual improvement of diagnosis and the difference in efficacy in the specific diagnosis and treatment process, such as the comprehensive plan formulated before surgery may be appropriately adjusted according to the surgical situation and postoperative pathological examination results, but the adjustment of each program should have a scientific basis.